Icometrix
The company develops FDA-cleared and CE-marked AI software, known as icobrain, that automatically quantifies brain MRI scans to assist radiologists and neurologists. Its solutions provide longitudinal monitoring and volumetric analysis for conditions including multiple sclerosis, Alzheimer’s disease, traumatic brain injury, epilepsy, and Parkinson’s disease. Recently acquired by GE HealthCare, the platform integrates into clinical workflows to support data-driven diagnosis and treatment decisions.
Healthtech
Artificial Intelligence
Medical Imaging
Neurology
Funding summary
- Total raised
- €17.5M
- Funding rounds
- 2
Investors in Icometrix
Investors on record for Icometrix. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Icometrix?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors